- Home
- AUTL vs FRPH Comparison
AUTL vs FRPH Comparison
Compare AUTL & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUTL | FRPH |
|---|---|---|
| Founded | 2014 | 1986 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 420.6M |
| IPO Year | 2025 | 1995 |
Fundamental Metrics
Financial Performance| Metric | AUTL | FRPH |
|---|---|---|
| Price | $1.90 | $21.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 94.8K |
| Earning Date | 05-14-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $10,120,000.00 | ★ $42,846,000.00 |
| Revenue This Year | $80.32 | N/A |
| Revenue Next Year | $53.96 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 496.00 | 2.57 |
| 52 Week Low | $1.18 | $20.53 |
| 52 Week High | $2.58 | $25.74 |
Technical Indicators
Market Signals| Indicator | AUTL | FRPH |
|---|---|---|
| Relative Strength Index (RSI) | 41.61 | 42.21 |
| Support Level | $1.37 | $21.87 |
| Resistance Level | $2.07 | $23.10 |
| Average True Range (ATR) | 0.10 | 0.53 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 15.00 | 19.12 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, industrial, and office (the Development Segment), and (iv) management of mixed-use residential/retail properties owned through joint ventures.